Company Overview
About Medtronic
Medtronic plc is the world's largest medical device company, founded in 1949 by Earl Bakken and Palmer Hermundslie in a Minneapolis, Minnesota garage—where Bakken invented the first wearable external pacemaker—and now incorporated in Ireland with operational headquarters in Dublin, trading on NYSE (MDT). The company generated approximately $32.4 billion in revenues for fiscal year 2024 (ending April 26, 2024) under CEO Geoff Martha, spanning cardiovascular, neuroscience, surgical, and diabetes therapy technologies. Medtronic's 2015 acquisition of Covidien for $49.9 billion—at the time the largest medical device merger in history—added surgical instruments, patient monitoring, and respiratory interventions while enabling Irish incorporation that reduced the company's effective tax rate. In 2024, Medtronic announced the spin-off of its Patient Monitoring & Respiratory Interventions segment as an independent company (NewCo), sharpening focus on higher-margin, high-growth therapy areas.
Business Model & Competitive Advantage
Medtronic's cardiovascular portfolio—the largest revenue contributor—includes implantable cardiac defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, cardiac ablation systems (Affera and Arctic Front cryoablation), transcatheter heart valves (Evolut TAVR competing with Edwards Lifesciences), and electrophysiology mapping systems. The neuromodulation portfolio includes deep brain stimulation (DBS) systems for Parkinson's disease and essential tremor, spinal cord stimulation for chronic pain, and neurovascular intervention catheters. Hugo, Medtronic's soft-tissue robotic-assisted surgery system, received CE Mark and international approvals and is being deployed to challenge Intuitive Surgical's da Vinci monopoly in soft-tissue robotic surgery—a market Medtronic is pursuing aggressively given its global hospital relationships and installed base of surgical products.
Competitive Landscape 2025–2026
In 2025-2026, Medtronic competes with Abbott Laboratories (cardiac rhythm), Edwards Lifesciences (structural heart valves), Boston Scientific (cardiac electrophysiology, endoscopy), Stryker (neurosurgery, spinal), and Intuitive Surgical (robotic surgery) across its major therapy areas. The diabetes segment's MiniMed 780G automated insulin delivery system competes with Insulet's Omnipod and Tandem Diabetes Care's Control-IQ in the closed-loop insulin pump market, with continuous glucose monitor integration through partnerships with Dexcom and Abbott. The company's global presence—generating approximately 45% of revenues outside the United States—provides diversification but also currency translation headwinds that have pressured reported growth versus constant-currency performance.
The Medtronic Story
Founders
Company Timeline
Major milestones in Medtronic's journey
Leadership Team
Meet the leaders behind Medtronic
Geoff S. Martha
Geoff Martha was named CEO in April 2020 after joining Medtronic in 2011 and holding various enterprise-level leadership roles in strategy, corporate development, and oversight of business units. His total compensation for fiscal 2025 was $23.3 million, reflecting strong company performance and strategic execution. Martha leads Medtronic's focus on accelerating innovation, expanding market positions, and driving operational excellence.
Thierry Piéton
Thierry Piéton serves as EVP and CFO, overseeing all financial operations, investor relations, treasury, tax, and financial planning for Medtronic's $33+ billion annual revenue operation. He manages capital allocation, financial reporting, and strategic financial planning supporting the company's long-term growth objectives.
Sean Salmon
Sean Salmon leads Medtronic's largest business segment, the Cardiovascular Portfolio, which includes cardiac rhythm management, structural heart therapies, coronary and peripheral vascular interventions, and mechanical circulatory support. He drives innovation and market expansion across cardiovascular technologies that serve millions of patients with heart disease globally.
Gregory Smith
Gregory Smith oversees Medtronic's global manufacturing operations, supply chain management, logistics, and quality systems across the company's worldwide network of production facilities. He ensures reliable supply of life-saving medical devices while driving operational efficiency, quality excellence, and supply chain resilience.
Lars Reger
Lars Reger leads Medtronic's technology strategy, R&D investments totaling $2.7 billion annually, and innovation roadmap across all business segments. He drives the company's focus on AI, robotics, digital health, and advanced medical technologies that define the future of medical device innovation.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
Medtronic is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $32400M in revenue, Medtronic operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare Medtronic with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Medtronic? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Medtronic Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Medtronic vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →